MDRF Partners with embedUR for Advanced AI Models in Diabetic Research

This collaboration aims to enhance the efficacy of clinical studies and improve diabetes management in India.

The Madras Diabetes Research Foundation (MDRF) has joined forces with embedUR Systems to develop advanced AI models for diabetic research and management. 

This collaboration aims to enhance the efficacy of clinical studies and improve diabetes management in India.

As a result of the partnership, experts from MDRF and embedUR will collaborate to analyze extensive Continuous Glucose Monitoring (CGM) datasets. 

These datasets, comprising several thousand patient records, will be processed using AI tools developed by embedUR. The goal is to create sophisticated AI models that learn and improve continually.

Dr V Mohan, chairman of MDRF, and Rajesh C Subramanium, founder and CEO of embedUR Systems, signed the Memorandum of Understanding (MoU) at a press conference. 

Sharing thoughts, Dr Mohan said, "This partnership allows us to leverage AI to gain deeper insights into diabetes management. With the expertise of embedUR, we aim to develop models that can significantly enhance clinical outcomes."

The Collaboration Deal

The partnership seeks to develop AI models based on robust and relevant data. Further, the collaboration aims to create impactful solutions for diabetes care. 

The preliminary findings from the data analysis will guide the development of these AI models, ensuring they are built on a solid foundation.

Echoing similar thoughts, CEO Subramanium said, "Our collaboration with MDRF will enable us to utilize our AI and data analytics capabilities to address critical challenges in diabetes management. By combining our strengths, we can develop solutions that are precisely tailored to the needs of diabetes patients."

Latest Developments in Diabetes Care

In a related development, King George's Medical University (KGMU) in Lucknow acquired advanced machines and technologies to combat diabetic retinopathy, a condition caused by damage to the blood vessels in the retina due to uncontrolled blood sugar levels. Further, the state government allocated INR 2 Cr for this purpose.

Highlighting the impact of the funding, prof Sonia Nityanand, VC, KGMU, said, "The allocation will enable us to provide state-of-the-art facilities for the treatment of diabetic retinopathy. Patients in our ophthalmology department will now have access to specialized treatment and comprehensive care."

If left untreated, diabetic retinopathy can lead to vision loss and blindness. The new funding sought to facilitate the acquisition of advanced machines and services, enhancing KGMU's capacity to treat this serious eye condition.